N-[(2S,4S,6R)-2-(dihydroxymethyl)-4-hydroxy-3,3-dimethyl-7-oxo-4lambda~4~-thia-1-azabicyclo[3.2.0]hept-6-yl]-2-phenylacetamide

N-[(2S,4S,6R)-2-(dihydroxymethyl)-4-hydroxy-3,3-dimethyl-7-oxo- 4lambda~4~-thia- 1- azabicyclo[3.2.0]hept- 6- yl]-2- phenylacetamide is a synthetic compound classified as an experimental penicillin derivative and sometimes referred to as "oxidised penicillin G". It contains the core penam ring structure characteristic of the penicillins and is structurally related to beta-lactam antibiotics. The compound has been studied primarily for its interaction with the enzyme penicillin G acylase but does not have established clinical use or approved therapeutic indications[1][3][6]. Its mechanism of action would be expected to involve inhibition of bacterial cell wall synthesis via binding to and inactivating transpeptidase enzymes (penicillin-binding proteins), similar to other beta-lactams; however, this specific molecule appears mainly used in research contexts.

Other names

oxidised penicillin GSOXN-[2-(dihydroxymethyl)-4-hydroxy-3,3-dimethyl-7-oxo-thiaazabicycloheptyl]-2-phenylacetamide